Global PRRS Solutions
  • header_globalsolutions
  • Control

    Control
    • Control

      • Vaccination
      • 5 step process
      • Products
      • Biosecurity
      • Infection chain
      • Heterologous protection
  • PRRS: the disease

    PRRS: the disease
    • PRRS: the disease

      • The virus
      • Prevalence and strains
      • Transmission
      • Coinfections
      • Immunity against PRRSV
      • Symptoms
      • Reproductive symptoms
      • Respiratory symptoms
      • Cost of PRRS
      • Diagnostic
      • Detecting antibodies - ELISA
      • Detecting virus - PCR
      • Virus sequencing
      • Oral fluid sampling
  • Technical expertise

    Technical expertise
    • Technical expertise

      • Publications
      • PRRS abstracts
      • Articles about PRRS
      • Latest News
      • Videos about PRRS
      • Technical expertise
      • PRRS Awards
      • Contact PRRS experts
      • Recommended links
  • Training

    Training
    • Training

      • Webinars
      • Events

5 STEP PROCESS

5 Steps
  • 1

    Identify desired goals

  • 2

    Determine current PRRS status

  • 3

    Understand current constraints

  • 4

    Develop solution options

  • 5

    Implement and monitor preferred solutions

Feeling restricted about PRRS solutions
Feeling restricted about PRRS solutions
  • Home
  • PRRS Publications
  • PRRS abstracts

PRRS abstracts tagged with Ingelvac

tags

International Prrs Symposium , Ipvs , Ingelvac Prrs Mlv , Diagnostics , Immune Response , Leman , Epidemiology , Cross Protection , Esphm , Economic Impact

Efficacy of Ingelvac PRRS® MLV against a heterologous PRRSV 1-7-4 RFLP challenge

Efficacy of Ingelvac PRRS® MLV against a heterologous PRRSV 1-7-4 RFLP challenge

11-06-2018

Read more

PRRS abstracts

A field case vaccinating with Ingelvac® PRRS MLV to control PRRS NADC30-like strain in China

A field case vaccinating with Ingelvac® PRRS MLV to control PRRS NADC30-like strain in China

11-06-2018

Read more

PRRS abstracts

Routine production of PRRS virus negative weaned piglets from Ingelvac® PRRS MLV mass vaccinated, field virus positive sow herds.

Routine production of PRRS virus negative weaned piglets from Ingelvac® PRRS MLV mass vaccinated, field virus positive sow herds.

11-06-2018

Read more

PRRS abstracts

Boehringer
  • Contact
  • Imprint and terms of use
  • Data privacy
  • Recommended links
Preventions

2010 - 2018 Boehringer Ingelheim GmbH All rights reserved.